Interleukin-mediated therapies in liver diseases and comorbidity effects  

作　　者：Nouhoum Bouare Jean Delwaide 

机构地区：[1]Department of Quality,Hygien,Biosafety/Biosecurity and Pharmacovigilence,National Institute of Public Health,Bamako 1771,Mali [2]Department of Gastroenterology and Hepatology,CHULiege,Liege 4000,Belgium

出　　处：《World Journal of Hepatology》2024年第7期980-989,共10页世界肝病学杂志（英文版）（电子版）

摘　　要：Cytokines like interleukins(ILs)play important roles in inflammation and innate immune.Yang and Zhang carried out an interesting study related to ILs and hepatic diseases.They described the role of ILs in the pathogenesis and resolution of hepatic disorders.The authors summarized alcohol-related liver disease and virus-induced hepatitis,as far as clinical studies a fortiori carried out on ILmediated treatments pertaining to these dysfunctions.This editorial contributes to the review by Yang and Zhang titled,"Interleukins in liver disease treatment",and focuses on therapies mediated by ILs in comorbid liver diseases.The documentary search was conducted on recent pertinent literature,primarily using the Google Scholar and PubMed databases.

关 键 词：CYTOKINES INTERLEUKINS Liver diseases Therapy COMORBIDITY 

分 类 号：R575[医药卫生—消化系统]